aids - New meningitis vaccine from India An Indian company...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Sheet1 Page 1 New meningitis vaccine from India An Indian company called Serum Institute of India Ltd (SIIL) has, in collaboration with the World Health Organization (WHO) and Meningitis Vaccine Project (MVP), developed a new and affordable vaccine for meningococcal meningitis. This conjugate meningitis vaccine A (Men A) has been developed applying a new US Technology supplied by the US Food and Drug Administration. The joint venture will produce 25 millions doses of the vaccine every year at a cost as low as USD 0.40 cents per dose for the hyper-endemic sub-Saharan t meningitis belt$ of Africa. http://www.biopeer.com/biopeer/2005/07/new_meningitis_.html Source-->>http://www.who.int/mediacentre/news/releases/2007/pr28/en/index.html Source-->>http://www.meningvax.org/files/press-0603-improved.htm Above sources assures that there are ways to overcome high cost drug manufacturing. Its a simple coalition between WHO, PATH and SIIL. If such funding and co-operation can work in developing Meningitis Vaccine then why not in confronting Aids/HIV. ------------------------------------------------------------------------ MVP, a partnership between the World Health Organization (WHO) and the Seattle-based nonprofit, PATH, is collaborating with a
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 3

aids - New meningitis vaccine from India An Indian company...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online